首页>投融资
iVEAcare
A轮
iVEAcare致力于开发和商业化下一代神经调控技术平台，以治疗慢性疾病患者。我们是连续创业者、投资者和经营者，在植入式医疗器械领域拥有丰富的经验，并在生物电子领域成功创办了多家公司。我们与一流的医生合作，共同解决沉重的慢性疾病负担，并得到拥有深厚领域专业知识的风险投资合作伙伴的支持。
基本信息
-
公司全称iVEAcare
-
类型神经调控技术平台开发商
-
产业领域医疗器械、治疗设备
-
公司人数不明确
-
地址
-
联系电话
-
邮箱
-
成立时间2023-01-01
投融资
-
2024-04-22A轮2750万美元Vensana CapitalHatteras Venture PartnersTreo Ventures
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司，该公司开发了一种先进的放疗平台，能够对不可切除的实体瘤和手术切缘进行局部靶向治疗，称为YntraDose。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息